The role of thoracic surgery in the management of mesothelioma: an expert opinion on the limited evidence

References

• Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet. 2005;366(9483):397–408.
   PubMed Web of Science ®Google Scholar
• Gilham C, Rake C, Burdett G, et al. Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden. Occup Environ Med. 2015 Dec 29. pii:oemed-2015-103074 (Epub ahead of print)
   PubMedGoogle Scholar
• Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353(15):1591–1603.
   PubMed Web of Science ®Google Scholar
• Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European respiratory society and the European society of thoracic surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35(3):479–495.
   PubMed Web of Science ®Google Scholar
• Rake C,Gilham C, Hatch J, et al. Occupational, domestic and environmental mesothelioma risks in Britain: a case-control study. Br J Cancer. 2009;100:1175-1183.
   Google Scholar
• van Zandwijk N, Clarke C, Henderson D. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis. 2013;5(6):E254–E307.
   PubMed Web of Science ®Google Scholar
• Balduyck B, Trousse D, Nakas A, et al. Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile? Ann Thorac Surg. 2010;89(3):907–911.
   PubMed Web of Science ®Google Scholar
• Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg. 2008;135(3):620–623.
   PubMed Web of Science ®Google Scholar
• Blomberg C, Nilsson J, Holgersson G, et al. Randomized trials of systemic medically-treated malignant mesothelioma: a systematic review. Anticancer Res. 2015;35(5):2493–2501.
   PubMed Web of Science ®Google Scholar
• Opitz I, Friess M, Kestenholz P, et al. A new prognostic score supporting treatment allocation for multimodality therapy for malignant pleural mesothelioma: a review of 12 years’ experience. J Thorac Oncol. 2015;10(11):1634–1641.
   PubMed Web of Science ®Google Scholar
• Cardillo G, Facciolo F, Carbone L, et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothorac Surg. 2002;21(2):302–306; discussion 305-6.
   PubMed Web of Science ®Google Scholar
• Bueno R, Reblando J, Glickman J, et al. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg. 2004;78(5):1774–1776.
   PubMed Web of Science ®Google Scholar
• Greillier L, Cavailles A, Fraticelli A, et al. Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma. Cancer. 2007;110(10):2248–2252.
   PubMed Web of Science ®Google Scholar
• Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet. 2003;361(9366):1326–1330.
   PubMed Web of Science ®Google Scholar
• Kao SC-H, Yan TD, Lee K, et al. Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma. J Thorac Oncol. 2011;6(3):602–605.
   PubMed Web of Science ®Google Scholar
• Churg A. Tumors of the pleura. In: Travis WD, Brambilla E, Muller-Hermelink HK, editors. World Health Organisation classification of tumors, pathology and genetics of the tumors of the lung, pleura, thymus and heart. Lyon, France: IARC press; 2004.
   Google Scholar
• Chamberlain MH, Fareed K, Nakas A, et al. Video-assisted cervical thoracoscopy: a novel approach for diagnosis, staging and pleurodesis of malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2008;34(1):200–203.
   PubMed Web of Science ®Google Scholar
• de Perrot M, Uy K, Anraku M, et al. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2007;133(1):111–116.
   PubMed Web of Science ®Google Scholar
• Pilling JE, Stewart DJ, Martin-Ucar AE, et al. The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2004;25(4):497–501.
   PubMed Web of Science ®Google Scholar
• Edwards JG, Stewart DJ, Martin-Ucar A, et al. The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma. J Thorac Cardiovasc Surg. 2006;131(5):981–987.
   PubMed Web of Science ®Google Scholar
• Sørensen JB, Ravn J, Loft A, et al. Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy. Eur J Cardiothorac Surg. 2008;34(5):1090–1096.
   PubMed Web of Science ®Google Scholar
• Rice DC, Erasmus JJ, Stevens CW, et al. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg. 2005;80(6):1988–1992; discussion 1992-3.
   PubMed Web of Science ®Google Scholar
• Rice DC, Steliga MA, Stewart J, et al. Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg. 2009;88(3):862–869; discussion 868-9.
   PubMed Web of Science ®Google Scholar
• Ghigna MR, Crutu A, Florea V, et al. The role of endobronchial ultrasound-guided fine needle aspiration in the diagnosis of pleural mesothelioma. Cytopathology. 2015. doi:10.1111/cyt 12263 (Epub ahead of print)
   PubMedGoogle Scholar
• Lococo F, Rossi G, Agostini L, et al. “Dry” pleural mesothelioma successfully diagnosed on endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA). Intern Med. 2014;53(5):467–469.
   PubMed Web of Science ®Google Scholar
• Nakas A, Waller D, Lau K, et al. The new case for cervical mediastinoscopy in selection for radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2012;42(1):72–76; discussion 76.
   PubMed Web of Science ®Google Scholar
• Zielinski M, Hauer J, Hauer L, et al. Staging algorithm for diffuse malignant pleural mesothelioma. Interact Cardiovasc Thorac Surg. 2010;10(2):185–189.
   PubMed Web of Science ®Google Scholar
• Halstead JC, Lim E, Venkateswaran RM, et al. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Eur J Surg Oncol. 2005;31(3):314–320.
   PubMed Web of Science ®Google Scholar
• Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev. 2004;1:CD002916.
   PubMedGoogle Scholar
• Rena O, Boldorini R, Papalia E, et al. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma. Ann Thorac Surg. 2015;99(4):1177–1183.
   PubMed Web of Science ®Google Scholar
• Waller DA, Morritt GN, Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest. 1995;107(5):1454–1456.
   PubMed Web of Science ®Google Scholar
• Rintoul RC, Ritchie AJ, Edwards JG, et al. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial. Lancet. 2014;384(9948):1118–1127.
   PubMed Web of Science ®Google Scholar
• Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion: British thoracic society pleural disease guideline 2010. Thorax. 2010;65 Suppl 2:ii32–40.
   PubMed Web of Science ®Google Scholar
• Nakas A, Martin Ucar AE, Edwards JG, et al. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2008;33(1):83–88.
   PubMed Web of Science ®Google Scholar
• Freeman RK, Ascioti AJ, Mahidhara RS. A propensity-matched comparison of pleurodesis or tunneled pleural catheter in patients undergoing diagnostic thoracoscopy for malignancy. Ann Thorac Surg. 2013;96(1):259–263; discussion 263-4.
   PubMed Web of Science ®Google Scholar
• Burt BM, Ali SO, DaSilva MC, et al. Clinical indications and results after chest wall resection for recurrent mesothelioma. J Thorac Cardiovasc Surg. 2013;146(6):1373–1380; discussion 1379-80.
   PubMed Web of Science ®Google Scholar
• Politi L, Borzellino G. Second surgery for recurrence of malignant pleural mesothelioma after extrapleural pneumonectomy. Ann Thorac Surg. 2010;89(1):207–210.
   PubMed Web of Science ®Google Scholar
• Sugarbaker DJ. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol. 2006;1(2):175–176.
   PubMed Web of Science ®Google Scholar
• Cameron RB. Extrapleural pneumonectomy is the preferred surgical management in the multimodality therapy of pleural mesothelioma: con argument. Ann Surg Oncol. 2007;14(4):1249–1253.
   PubMed Web of Science ®Google Scholar
• Flores RM. Pleurectomy decortication for mesothelioma: the procedure of choice when possible. J Thorac Cardiovasc Surg. 2016;151:310–312.
   Web of Science ®Google Scholar
• Rice D, Rusch V, Pass H, et al. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol. 2011;6(8):1304–1312.
   PubMed Web of Science ®Google Scholar
• Bovolato P, Casadio C, Billè A, et al. Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients. J Thorac Oncol. 2014;9(3):390–396.
   PubMed Web of Science ®Google Scholar
• Leuzzi G, Rea F, Spaggiari L, et al. Prognostic score of long-term survival after surgery for malignant pleural mesothelioma: a multicenter analysis. Ann Thorac Surg. 2015;100:890–897.
   PubMed Web of Science ®Google Scholar
• Nakas A, Waller D. Predictors of long-term survival following radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2014;46(3):380–385; discussion 385.
   PubMed Web of Science ®Google Scholar
• Cao C, Yan TD, Bannon PG, et al. Summary of prognostic factors and patient selection for extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. Ann Surg Oncol. 2011;18(10):2973–2979.
   PubMed Web of Science ®Google Scholar
• Rusch VW, Giroux D, Kennedy C, et al. Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol. 2012;7(11):1631–1639.
   PubMed Web of Science ®Google Scholar
• Sugarbaker DJ, Richards WG, Bueno R. Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients. Ann Surg. 2014;260(4):577–580; discussion 580-2.
   PubMed Web of Science ®Google Scholar
• Lang-Lazdunski L, Bille A, Papa S, et al. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience. J Thorac Cardiovasc Surg. 2015;149(2):558–6; discussion 565-6.
   PubMed Web of Science ®Google Scholar
• Sharkey AJ, Tenconi S, Nakas A, et al. The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy/decortication†. Eur J Cardiothorac Surg. Eur J Cardiothorac Surg. 2015; pii:ezv403. (Epub ahead of print)
   PubMedGoogle Scholar
• Ghanim B, Hoda MA, Klikovits T, et al. Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma. Br J Cancer. 2014;110(4):984–990.
   PubMed Web of Science ®Google Scholar
• Kao SC, Vardy J, Chatfield M, et al. Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board. Clin Lung Cancer. 2013;14(1):70–77.
   PubMed Web of Science ®Google Scholar
• Cao CQ, Yan TD, Bannon PG, et al. A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol. 2010;5(10):1692–1703.
   PubMed Web of Science ®Google Scholar
• Opitz I, Kestenholz P, Lardinois D, et al. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2006;29(4):579–584.
   PubMed Web of Science ®Google Scholar
• de Perrot M, McRae K, Anraku M, et al. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Thorac Surg. 2008;85(4):1206–1210.
   PubMed Web of Science ®Google Scholar
• Stewart DJ, Martin-Ucar AE, Edwards JG, et al. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations. Eur J Cardiothorac Surg. 2005;27(3):373–378.
   PubMed Web of Science ®Google Scholar
• Edwards JG, Martin-Ucar AE, Stewart DJ, et al. Right extrapleural pneumonectomy for malignant mesothelioma via median sternotomy or thoracotomy? Short- and long-term results. Eur J Cardiothorac Surg. 2007;31(5):759–764.
   PubMed Web of Science ®Google Scholar
• Rusch VW, Rosenzweig K, Venkatraman E, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2001;122(4):788–795.
   PubMed Web of Science ®Google Scholar
• Van Schil PE, Baas P, Gaafar R, et al. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J. 2010;36(6):1362–1369.
   PubMed Web of Science ®Google Scholar
• de Perrot M, Feld R, Cho BCJ, et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27(9):1413–1418.
   PubMed Web of Science ®Google Scholar
• Weder W, Stahel RA, Bernhard J, et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol. 2007;18(7):1196–1202.
   PubMed Web of Science ®Google Scholar
• Spaggiari L, Marulli G, Bovolato P, et al. Extrapleural pneumonectomy for malignant mesothelioma: an Italian multicenter retrospective study. Ann Thorac Surg. 2014;97(6):1859–1865.
   PubMed Web of Science ®Google Scholar
• Rena O, Casadio C. Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure. Lung Cancer. 2012;77(1):151–155.
   PubMed Web of Science ®Google Scholar
• Ambrogi V, Mineo D, Gatti A, et al. Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma. J Surg Oncol. 2009;100(3):199–204.
   PubMed Web of Science ®Google Scholar
• Teh E, Fiorentino F, Tan C, et al. A systematic review of lung-sparing extirpative surgery for pleural mesothelioma. J R Soc Med. 2011;104(2):69–80.
   PubMed Web of Science ®Google Scholar
• Cao C, Tian DH, Pataky KA, et al. Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma. Lung Cancer. 2013;81(3):319–327.
   PubMed Web of Science ®Google Scholar
• Burt BM, Cameron RB, Mollberg NM, et al. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality. J Thorac Cardiovasc Surg. 2014;148(1):30–35.
   PubMed Web of Science ®Google Scholar
• Lang-Lazdunski L, Bille A, Lal R, et al. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol. 2012;7(4):737–743.
   PubMed Web of Science ®Google Scholar
• Bölükbas S, Eberlein M, Kudelin N, et al. Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2013;44(1):119–123.
   PubMed Web of Science ®Google Scholar
• Rosenzweig KE, Zauderer MG, Laser B, et al. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2012;83(4):1278–1283.
   PubMed Web of Science ®Google Scholar
• Bölükbas S, Eberlein M, Schirren J. Prospective study on functional results after lung-sparing radical pleurectomy in the management of malignant pleural mesothelioma. J Thorac Oncol. 2012;7(5):900–905.
   PubMed Web of Science ®Google Scholar
• Williams T, Duraid H, Watson S, et al. Extended pleurectomy and decortication for malignant pleural mesothelioma is an effective and safe cytoreductive surgery in the elderly. Ann Thorac Surg. 2015;100(5):1868–1874.
   PubMed Web of Science ®Google Scholar
• Krug LM, Pass HI, Rusch VW, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27(18):3007–3013.
   PubMed Web of Science ®Google Scholar
• Bölükbas S, Eberlein M, Fisseler-Eckhoff A, et al. Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections. Lung Cancer. 2013;81(2):241–246.
   PubMed Web of Science ®Google Scholar
• Sugarbaker DJ, Gill RR, Yeap BY, et al. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg. 2013;145(4):955–963.
   PubMed Web of Science ®Google Scholar
• Lucchi M, Chella A, Melfi F, et al. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2007;31(3):529–4; discussion 533-4.
   PubMed Web of Science ®Google Scholar
• de Bree E, van Ruth S, Schotborgh CE, et al. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin. Ann Surg Oncol. 2007;14(10):3019–3026.
   PubMed Web of Science ®Google Scholar
• Gomez D, Tsao AS. Local and systemic therapies for malignant pleural mesothelioma. Curr Treat Options Oncol. 2014;15(4):683–699.
   PubMed Web of Science ®Google Scholar
• Friedberg JS, Culligan MJ, Mick R, et al. Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. Ann Thorac Surg. 2012;93(5):1658–7; discussion 1665-7.
   PubMed Web of Science ®Google Scholar
• Munck C, Mordon SR, Scherpereel A, et al. Intrapleural photodynamic therapy for mesothelioma: what place and which future? Ann Thorac Surg. 2015;99(6):2237–2245.
   PubMed Web of Science ®Google Scholar
• Gomez DR, Hong DS, Allen PK, et al. Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. J Thorac Oncol. 2013;8(2):238–245.
   PubMed Web of Science ®Google Scholar
• Stahel R, Riesterer O, Xyrafas A, et al. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. Lancet Oncol. 2015;15:S1470–S2045.
   Google Scholar
• de perrot M, Feld R, Leighl NB, et al. Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2016;151:468–475.
   PubMed Web of Science ®Google Scholar
• Minatel E, Trovo M, Polesel J, et al. Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up. Lung Cancer. 2014;83(1):78–82.
   PubMed Web of Science ®Google Scholar
• Rimner A, Spratt DE, Zauderer MG, et al. Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2014;90(2):394–401.
   PubMed Web of Science ®Google Scholar
• Bölükbas S, Manegold C, Eberlein M, et al. Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy. Lung Cancer. 2011;71(1):75–81.
   PubMed Web of Science ®Google Scholar
• Schipper PH, Nichols FC, Thomse KM, et al. Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg. 2008;85(1):257–264; discussion 264.
   PubMed Web of Science ®Google Scholar
• Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol. 2011;12(8):763–772.
   PubMed Web of Science ®Google Scholar
• Weder W, Stahel RA, Baas P, et al. The MARS feasibility trial: conclusions not supported by data. Lancet Oncol. 2011;12(12):1093–1095; author reply 1094-5.
   PubMed Web of Science ®Google Scholar
• Nakas A, Von Meyenfeldt E, Lau K, et al. Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2012;41(5):1031–1036.
   PubMed Web of Science ®Google Scholar
• Cao C, Tian D, Park J, et al. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer. 2014;83(2):240–245.
   PubMed Web of Science ®Google Scholar
• Taioli E, Wolf AS, Flores RM. Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg. 2015;99(2):472–480.
   PubMed Web of Science ®Google Scholar
• Hiddinga BI, van Meerbeeck JP. Surgery in mesothelioma–where do we go after MARS? J Thorac Oncol. 2013;8(5):525–529.
   PubMed Web of Science ®Google Scholar
• Rena O. Extrapleural pneumonectomy in malignant pleural mesothelioma. BMJ. 2011;343:d5706.
   PubMed Web of Science ®Google Scholar
• Lang-Lazdunski L. Surgery for malignant pleural mesothelioma: why, when and what? Lung Cancer. 2014;84(2):103–109.
   PubMed Web of Science ®Google Scholar
• Opitz I. Management of malignant pleural mesothelioma-The European experience. J Thorac Dis. 2014;6 Suppl 2:S238–S252.
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Akerley W, Borghaei H, et al. Malignant pleural mesothelioma. J Natl Compr Canc Netw. 2012;10(1):26–41.
   PubMed Web of Science ®Google Scholar
• Waller DA. Lung-sparing total pleurectomy: the surgical option of choice in malignant pleural mesothelioma? Eur J Cardiothorac Surg. 2013;44(1):123–124.
   PubMed Web of Science ®Google Scholar
• Rusch V, Baldini EH, Bueno R, et al. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg. 2013;145(4):909–910.
   PubMed Web of Science ®Google Scholar
• Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg. 1999;68(5):1799–1804.
   PubMed Web of Science ®Google Scholar
• Utley M, Fiorentino F, Treasure T. Obtaining an upper estimate of the survival benefit associated with surgery for mesothelioma. Eur J Cardiothorac Surg. 2010;38(3):241–244.
   PubMed Web of Science ®Google Scholar
• Nakano T, Hamanaka R, Oiwa K, et al. Localized malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg. 2012;60(7):468–474.
   PubMedGoogle Scholar
• Nakas A, Martin-Ucar AE, Edwards JG, et al. Localised malignant pleural mesothelioma: a separate clinical entity requiring aggressive local surgery. Eur J Cardiothorac Surg. 2008;33(2):303–306.
   PubMed Web of Science ®Google Scholar
• Tanzi S, Tiseo M, Internullo E, et al. Localized malignant pleural mesothelioma: report of two cases. J Thorac Oncol. 2009;4(8):1038–1040.
   PubMed Web of Science ®Google Scholar